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IMPORTANCE Tourette syndrome (TS) is characterized by high rates of psychiatric comorbidity;
however, few studies have fully characterized these comorbidities. Furthermore,most studies
have included relatively few participants (<200), and none has examined the ages of highest
risk for each TS-associated comorbidity or their etiologic relationship to TS.
OBJECTIVE To characterize the lifetime prevalence, clinical associations, ages of highest risk,
and etiology of psychiatric comorbidity among individuals with TS.
DESIGN, SETTING, AND PARTICIPANTS Cross-sectional structured diagnostic interviews
conducted between April 1, 1992, and December 31, 2008, of participants with TS (n = 1374)
and TS-unaffected family members (n = 1142).
MAIN OUTCOMES ANDMEASURES Lifetime prevalence of comorbidDSM-IV-TR disorders, their
heritabilities, ages of maximal risk, and associations with symptom severity, age at onset, and
parental psychiatric history.
RESULTS The lifetime prevalence of any psychiatric comorbidity among individuals with TS
was 85.7%; 57.7% of the population had 2 ormore psychiatric disorders. Themean (SD)
number of lifetime comorbid diagnoses was 2.1 (1.6); themean number was 0.9 (1.3) when
obsessive-compulsive disorder (OCD) and attention-deficit/hyperactivity disorder (ADHD)
were excluded, and 72.1% of the individuals met the criteria for OCD or ADHD. Other disorders,
includingmood, anxiety, and disruptive behavior, each occurred in approximately 30%of the
participants. The age of greatest risk for the onset of most comorbid psychiatric disorders was
between 4 and 10 years, with the exception of eating and substance use disorders, which
began in adolescence (interquartile range, 15-19 years for both). Tourette syndromewas
associatedwith increased risk of anxiety (odds ratio [OR], 1.4; 95%CI, 1.0-1.9; P = .04) and
decreased risk of substance use disorders (OR, 0.6; 95%CI, 0.3-0.9; P = .02) independent
from comorbid OCD and ADHD; however, high rates of mood disorders among participants
with TS (29.8%)may be accounted for by comorbid OCD (OR, 3.7; 95%CI, 2.9-4.8; P < .001).
Parental history of ADHDwas associatedwith a higher burden of non-OCD, non-ADHD
comorbid psychiatric disorders (OR, 1.86; 95%CI, 1.32-2.61; P < .001). Genetic correlations
between TS andmood (RhoG, 0.47), anxiety (RhoG, 0.35), and disruptive behavior disorders
(RhoG, 0.48), may be accounted for by ADHD and, for mood disorders, by OCD.
CONCLUSIONS AND RELEVANCE This study is, to our knowledge, themost comprehensive of
its kind. It confirms the belief that psychiatric comorbidities are common among individuals
with TS, demonstrates that most comorbidities begin early in life, and indicates that certain
comorbidities may bemediated by the presence of comorbid OCD or ADHD. In addition,
genetic analyses suggest that some comorbidities may bemore biologically related to OCD
and/or ADHD rather than to TS.
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T ourette syndrome (TS) is a childhood-onset neuro-psychiatric disorder characterized by multiple motortics and 1 or more vocal tics that persist for at least 1
year.1,2 Multiple comorbid psychiatric disorders have been
reported in TS-affected individuals; when present, these
conditions typically cause more distress and impairment
than do tics.3-7 High rates of comorbid attention-deficit/
hyperactivity disorder (ADHD) and obsessive-compulsive
disorder (OCD) have been well documented and are thought
to be core components of the TS phenotype.4,8-11 Although
elevated rates for mood disorders, nonobsessional anxiety
disorders, and disruptive behavior disorders (DBDs) have
also been reported,4,12-17 a significant gap in knowledge still
exists regarding the range, prevalence, and clinical attri-
butes of the non-OCD, non-ADHD comorbid disorders. The
few available studies were limited by small sample sizes
(<200 participants),3,7,18-20 small number of diagnoses
examined, or reliance on symptom checklists and severity
scales rather than DSM-based, structured diagnostic psychi-
atric assessments.18,21-24
Despite methodologic limitations, these studies12,13,15
suggest that a high proportion of individuals with TS
(61%-96%) have at least 1 comorbid psychiatric disorder.
Unfortunately, there is no consensus regarding expected
rates of the noncore (ie, non-OCD, non-ADHD) psychiatric
disorders in TS-affected individuals; in addition, there is
limited knowledge regarding typical age at onset, ages of
highest risk, and association with impairment for these dis-
orders.
Although the shared genetic susceptibility to OCD and
ADHD in TS-affected families has been established,25-27 the
etiologic relationships between TS and other psychiatric dis-
orders have not been examined. Elevated rates of psychiat-
ric comorbidity may arise from (1) shared genetic suscepti-
bility with TS, (2) shared genetic susceptibility with
comorbid OCD or ADHD, or (3) nongenetic factors (eg, shared
environment). Together with quantifying the extent of con-
comitant occurrence, understanding the clinical and etio-
logic relationships between TS, OCD, ADHD, and other psy-
chiatric comorbidities will help in understanding the sources
of heterogeneity of this complex neuropsychiatric disorder.
Therefore, the aims of the present study were to quantify
psychiatric disorder burden, ages of highest risk, and under-
lying genetic relationship of psychiatric disorders in
TS-affected individuals using the largest, most comprehen-
sive data set available.
Methods
The study was described to all participants; adults provided
written informed consent and children written assent before
participating. Parents providedwritten consent for their chil-
dren’s participation. Institutional review board approval was
obtained from all participating sites. The participants did not
receive financial compensation. The eAppendix in the
Supplement includes the inclusion and exclusion criteria and
informed consent details.
Participants
Phenotypic data were collected for genetic studies from TS-
affected individuals aged6yearsorolder and theirparents and
siblings, ascertained from802 independent families between
April 1, 1992, and December 31, 2008. Recruitment primarily
occurred fromticdisorder specialtyclinics in theUnitedStates,
Canada,GreatBritain, and theNetherlands aswell as from the
Tourette Syndrome Association of the United States.
Phenotypic Assessments
A psychiatrist, neurologist, or psychologist trained in the use
of clinical research assessments evaluated all participants
(D.L.P., Y.D., M.A.G., C.I., R.A.K., P.S., W.M.M., D.C.C., R.K.,
M.M.R., andC.A.M.).28 Tics, OCD, andADHDsymptomswere
assessed using a structured clinical interview specifically de-
veloped for TS genetic studies (eAppendix in the Supple-
ment). TheStructuredClinical InterviewforDSM-IVAxis IDis-
orders–Non-PatientEdition,2.029 (all sitesexcept theUniversity
ofUtahsite)or theSchedule forAffectiveDisordersandSchizo-
phrenia–Lifetime Version, Modified for the Study of Anxiety
Disorders30 (University of Utah site) was used to gather data
on DSM-IV-TR diagnoses for adults. The Schedule for Affec-
tiveDisorders andSchizophrenia for School-AgeChildren, the
Lifetime Version31 (all sites except Johns Hopkins University
School ofMedicine orUniversity of Toronto) or theEpidemio-
logic Version32 (JohnsHopkins University School ofMedicine
and University of Toronto sites) was used to collect data on
DSM-IV-TRdiagnoses in children and adolescents. Final diag-
noses were assigned using a best-estimate process, which re-
quiresdiagnostic consensusbyat least2 raters.28,33Wegrouped
individualdisorders intoDSM-IV-TR–basedcategories (eg,anxi-
ety disorders) to aid in clinical interpretation. The eAppendix
in the Supplement includes details regarding diagnostic in-
struments, rater training and reliability, age-at-onset deter-
mination, and the best-estimate process.
Statistical Analysis
For lifetime prevalence estimates of comorbid disorders and
ages at onset, we limited the sample to the 1374 participants
with TS. We also examined the lifetime prevalence of disor-
ders among probands compared with their TS-affected first-
degree relatives (eAppendix in the Supplement). To examine
the association amongTS,OCD, andADHDwith other comor-
bid disorders and for heritability analyses, we included all in-
dividuals, includingTS-unaffected familymembers.Wecom-
pared the rates of comorbid disorders by sex and age at
interviewusing χ2 andFisher exact tests.Weexamined the re-
lationship betweenpsychiatric comorbidity andTS,OCD, and
ADHDbycomparing lifetimeprevalence ratesof comorbiddis-
orders among participants with TS only, TS and OCD only
(TS+OCD), TS and ADHD only (TS+ADHD), and TS with both
OCDandADHD (TS+OCD+ADHD)using χ2 tests.Weused gen-
eralizedestimatingequations toexamine theassociationofTS,
ADHD, andOCD (individually and in combination)with other
comorbid disorders, controlling for family relationships, age
at interview, and sex.
For each disorder, we graphed the number of individuals
with each age at onset using violin plots along with the me-
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dianvalue and corresponding interquartile range.Age of high-
est riskwasdefined as the age atwhich the cumulative risk ex-
ceeded 10% (lower bound) through the upper bound of the
interquartile range.
Using generalized estimating equation models clustering
on family and controlling for age at interview and sex, we
tested the association between the presence of 1 or more
comorbid disorder (excluding OCD and ADHD) with OCD and
tic severity; OCD and ADHD; parental history of OCD, ADHD,
and TS; and TS, OCD, and ADHD ages at onset. To improve
clinical interpretation, we transformed continuous severity
measures into 3 categories (low, medium, and high) and ages
at onset into early and late onset so that there were approxi-
mately equal numbers of participants in each group. Vari-
ables from each generalized estimating equation model with
a significance level of P ≤ .20 were added simultaneously to
a multivariate model.
We calculated the additive genetic and environmental
correlations between TS and classes of comorbid disorders
using the Sequential Oligogenic Linkage Analysis Routines
(SOLAR, version 6.2.2)34 (eAppendix and eFigure in the
Supplement). For these analyses, TS was combined with
chronic motor or vocal tic disorders (CMVTDs). We did not
examine the heritability of psychotic or eating disorders
because of the low prevalence rates or of elimination disor-
ders because of missing parental data.
Results
Demographic Characteristics
The sample consisted of 1374 TS-affected individuals,
including parents or siblings without a TS diagnosis whomet
the best estimate criteria for TS (583 [42.4%]), and 1142
TS-unaffected first-degree relatives. The subsample of
TS-affected individuals showed a 3:1 male predominance
(1006 [73.2%] male), and the mean (SD) age at assessment
was 19.1 (13.5) years. Demographics and clinical characteris-
tics of TS-affected and TS-unaffected participants are pre-
sented in eTable 1 in the Supplement.
Overall Burden of Psychiatric Comorbidity
Of the participants with TS, 85.7% met the criteria for 1 or
more comorbid disorder (including OCD and ADHD) and
57.7%met the criteria for 2 or more comorbid disorders. Life-
time prevalence rates for classes of comorbid disorders are
summarized in Table 1; rates of individual disorders by sex
and age are presented in eTable 2 and eTable 3, respectively,
in the Supplement. The mean (SD) number of lifetime disor-
ders was 2.1 (1.6). When OCD and ADHD were excluded,
45.3% of the patients met the criteria for 1 or more comorbid
disorder and 23.6% met the criteria for 2 or more comorbid
disorders. The mean number of lifetime diagnoses, exclud-
ing OCD and ADHD, was 0.9 (1.3). There were no significant
differences in the rates of comorbid diagnoses between pro-
bands and TS-affected relatives when controlling for age at
assessment (eTable 4 in the Supplement); therefore, subse-
quent analyses combined these groups.
Prevalence of Specific Psychiatric Disorders
OCD and ADHD
Themost common comorbid psychiatric disorders were OCD
(50.0%) and ADHD (54.3%); 72.1% of the TS-affected partici-
pants met the criteria for either disorder. Females weremore
likely to have comorbid OCD (57.1% vs 47.5%; P < .01), and
males were more likely to have comorbid ADHD (58.5% vs
42.3%;P < .01).Nearlyone-third (29.5%)of theparticipantshad
TS+OCD+ADHD,20.2%hadTS+OCD,22.4%hadTS+ADHD,and
Table 1. Lifetime Prevalence of Psychiatric Disorders by Sex
Comorbid Disorder
No./Total No. With Available Data (%)
P ValueaAll TS-Affected Participants
Sex
Male Female
Obsessive-compulsive spectrumb 904/1368 (66.1) 645/1001 (64.4) 259/367 (70.6) .03
Attention-deficit/hyperactivity 713/1314 (54.3) 564/962 (58.6) 149/352 (42.3) <.001
Moodc 277/930 (29.8) 184/690 (26.7) 93/240 (38.8) <.001
Anxietyd 343/949 (36.1) 225/703 (32.0) 118/246 (48.0) <.001
Disruptive behaviore 185/622 (29.7) 157/493 (31.8) 28/129 (21.7) .03
Eatingf 19/937 (2.0) 2/693 (0.3) 17/244 (7.0) <.001
Psychoticg 7/931 (0.8) 5/689 (0.7) 2/242 (0.8) .88
Substance useh 59/948 (6.2) 42/701 (6.0) 17/247 (6.9) .62
Eliminationi 108/668 (16.2) 90/531 (17.0) 18/137 (13.1) .28
Abbreviation: TS, Tourette syndrome.
a The χ2 or Fisher exact test was used to compare rates of each disorder in
males vs females.
bObsessive-compulsive disorder and subclinical obsessive-compulsive disorder.
c Major depressive disorder, dysthymia, and bipolar disorder I and II.
dGeneralized anxiety disorder, panic disorder, agoraphobia without panic,
posttraumatic stress disorder, separation anxiety disorder, social phobia, and
specific phobia.
e Oppositional defiant and conduct disorders.
f Anorexia and bulimia nervosa.
g Schizophrenia and psychotic disorder, not otherwise specified.
h Alcohol and other substance use or dependence, excluding tobacco use.
i Enuresis and encopresis.
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27.9% had TS only. There was a significant interaction of sex
andagewithdiagnosticgroup(χ2 = 43.1,P < .001;andχ2 = 121.6,
P < .001, respectively).
Other Conditions
AfterOCDandADHD,mooddisorders, anxiety disorders, and
DBDs were the most prevalent classes of psychiatric comor-
bidity, each affecting approximately 30% of TS-affected par-
ticipants; psychotic disorders were the least common (<1%).
The prevalence of individual disorders ranged from0.5% (bi-
polar II disorder) to 26.1% (majordepressivedisorder) (eTables
2-5 in the Supplement). Femalesweremore likely to havema-
jordepressivedisorder,most anxietydisorders, andeatingdis-
orders.Malesweremore likely to haveADHDandDBD (oppo-
sitional defiant disorder or conduct disorder) (Table 1 and
eTable2 in theSupplement).Adultsandadolescentsweremost
likely to have OCD as well as mood, anxiety, eating, and sub-
stanceusedisorders,whereaschildrenweremore likely tohave
ADHD (eTable 3 in the Supplement).
There was a clear relationship between OCD, ADHD, and
the other psychiatric comorbidities in TS-affected partici-
pants. Mood, anxiety, and substance use disorders were
more prevalent among participants with TS+OCD and
TS+OCD+ADHD than among thosewith TS-only or TS+ADHD.
Disruptive behavior disorders and psychotic disorders were
moreprevalent amongparticipantswithTS+OCD+ADHDthan
among theother 3 groups (Figure 1 andeTable 5 in the Supple-
ment). When these analyses were repeated for males and fe-
males separatelyusing thediagnosticgroupsshowninFigure 1,
patternsofsignificanceforχ2analyseswerecomparabletothose
for all TS-affected participants combined, except for psy-
chotic disorders, which is attributable to small sample sizes
(eTable 5 in the Supplement).
To assess the relationships between TS, OCD, ADHD, and
psychiatric comorbidity, we conducted a multivariate gener-
alized estimating equation model in all individuals (eTable 6
in the Supplement). After controlling for OCD and ADHD, TS
was independently associatedwith an increased risk of anxi-
etydisorders (odds ratio [OR], 1.4; 95%CI, 1.0-1.9;P = .04) and
a decreased risk of substance use disorder (OR, 0.6; 95% CI,
0.3-0.9; P = .02); there was no significant independent asso-
ciation between TS and mood disorder or DBD. Obsessive-
compulsive disorder was independently associated with a
2-fold or greater risk of mood disorders (OR, 3.8; 95% CI, 2.9-
4.9; P < .001), anxiety disorders (OR, 2.8; 95% CI, 2.2-3.6;
P < .001), DBDs (OR, 2.0; 95% CI, 1.4-2.9; P < .001), and sub-
stance use disorders (OR, 3.9; 95% CI, 2.5-6.0; P < .001). At-
tention-deficit/hyperactivity disorderwas independently as-
sociated with an increased risk of anxiety disorders (OR, 1.5;
95% CI, 1.2-2.0; P < .01) and DBDs (OR, 4.0; 95% CI, 2.6-6.2;
P < .001) butnot substanceuseormooddisorders. Therewere
nosignificant associationsbetweenTS,OCD,ADHD,andelimi-
nation or eating disorders. The results of these models build
on those summarized in Figure 1 because they control for the
age and sex of the participants.
Age of Highest Risk
Themedianageatonset forTSwas6years (interquartile range,
4-8years) (Figure2andeTable7 in theSupplement).Attention-
deficit/hyperactivity disorder andDBDhad the youngestme-
dian age at onset and earliest ages of highest risk (5 years: in-
terquartile ranges, 3-6 and 3-8, respectively). The high-risk
period began at age 4 years for anxiety disorders, 7 years for
mooddisorders, and 13 years for substanceuse andeatingdis-
orders.Comparedwithmales, females tendedtohave laterages
at onset of TS, DBDs, anxiety disorders, and mood disorders
(eTable 7 in the Supplement).
Clinical Correlates of Number of Psychiatric Disorders
High tic and moderate/high OCD symptom severity, lifetime
prevalence of ADHD or OCD, and parental history of TS/
CMVTDandADHDwereassociatedwithhaving 1ormorenon-
core psychiatric comorbidity in univariate analyses (Table 2).
In themultivariatemodel, onlyhigh tic severity (OR, 1.57; 95%
CI, 1.11-2.21;P = .01),ADHD(OR, 1.51; 95%CI, 1.12-2.03;P < .01),
OCD (OR, 1.77; 95% CI, 1.34-2.35; P < .001), and parental his-
Figure 1. Lifetime Prevalence of Comorbid Disorders by the Presence of Obsessive-Compulsive Disorder (OCD)
and Attention-Deficit/Hyperactivity Disorder (ADHD) Among IndividualsWith Tourette Syndrome (TS)
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tory of ADHD (OR, 1.55; 95% CI, 1.08-2.23; P = .02) remained
significant.Obsessive-compulsivedisorder severitywasomit-
ted from the multivariate model to avoid confounding with
OCD diagnosis.
Genetic RelationshipsWith TS
Consistent with previous findings,26,35 including those from
a subset of the current sample, TS/CMVTD, OCD, and ADHD
all demonstrated significant genetic correlations (eTable 8 in
the Supplement). In addition, TS/CMVTD had significant
genetic correlations with mood disorders (RhoG [SE], 0.47
[0.17]; P = .004), anxiety disorders (RhoG [SE], 0.35 [0.15];
P = .02), and DBDs (RhoG [SE], 0.40 [0.18]; P = .02); these
correlations were not significant when controlling for OCD
and ADHD (eTable 9 in the Supplement). Mood disorders,
anxiety disorders, and DBDs were also genetically correlated
with ADHD; these correlations remained significant after
controlling for TS/CMVTD and OCD (Table 3). Furthermore,
mood disorders were significantly genetically correlated
with OCD, even when controlling for TS/CMVTD and ADHD
(Table 3).
Discussion
To our knowledge, this study represents the most compre-
hensive examination to date of the extent and burden of
comorbid psychiatric disorders in TS and is the first to report
the ages of highest risk and etiologic relationships with TS
for a wide variety of psychiatric conditions. Our results have
implications both clinically and for ongoing research into the
causes and etiologic relationships between these psychiatric
disorders.
Clinical Relevance
Consistent with previous studies,3,4,12,15,36-39 we identified a
very high burden of psychiatric disorders. Our results sug-
gest that the vast majority of children with TS can be
expected to develop 1 or more comorbid psychiatric disorder
during their lifetime, and more than half will develop 2 dis-
orders. In addition to high rates of OCD (50.0%) and ADHD
(54.3%), we identified high rates of mood disorders (29.8%),
anxiety disorders (36.1%), DBDs (29.7%), and elimination
Figure 2. Ages at Onset for Comorbid Disorders Among IndividualsWith Tourette Syndrome (TS)
1 4641363126211611
Age at Onset, y
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Eating
Disorder
Substance use
Mood
OCD
Anxiety
TS
Elimination
Disruptive behavior
ADHD
Data points and bars represent
median ages at onset and
interquartile ranges, respectively.
The width of each plot is proportional
to the number of individuals with the
given age at TS onset.
ADHD indicates attention-deficit/
hyperactivity disorder;
OCD, obsessive-compulsive disorder.
Table 2. Clinical Predictors of Having 1 orMore Comorbid Disordera
Characteristic (Reference Value) Level OR (95% CI) P Value
Symptom severityb
Tic severity tertile (0-16)
17-21 1.18 (0.90-1.55) .24
22-30 1.87 (1.43-2.46)c <.001c
OCD severity tertile (0-2)
3-6 1.64 (1.26-2.13)c <.001c
7-12 2.86 (2.13-3.82)c <.001c
Comorbid condition
ADHD (no ADHD) ADHD present 1.93 (1.53-2.43)c <.001c
OCD (no OCD) OCD present 2.17 (1.75-2.70)c <.001c
Parental historyd
TS/CMVTD (parental TS/CMVTD absent) Parental TS/CMVTD present 1.33 (1.01-1.76)c .04c
OCD (parental OCD absent) Parental OCD present 1.11 (0.84-1.47) .46
ADHD (parental ADHD absent) Parental ADHD present 1.86 (1.32-2.61)c <.001c
Age at onset, y
TS (≥7) <7 1.02 (0.82-1.29) .84
OCD (≥8) <8 1.10 (0.74-1.64) .63
ADHD (≥5) <5 1.35 (0.90-2.01) .14
Abbreviations: ADHD, attention-
deficit/hyperactivity disorder;
CMVTD, chronic motor or vocal tic
disorder; OCD, obsessive-compulsive
disorder; OR, odds ratio; TS, Tourette
syndrome.
a Separate generalized estimating
equations, clustering on family and
controlling for age at interview and
sex, were modeled with the
presence of 1 or more comorbid
disorder other than ADHD or OCD
as the outcome and each clinical
characteristic as the predictor
variable.
b Symptom severity scales for tics and
obsessive-compulsive symptoms
are described in the eMethods in
the Supplement.
c Statistically significant.
d Parental history was available only
for probands and their full siblings.
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disorders (16.2%). We found relatively low rates of psychotic
disorders and substance abuse disorders at the time of
evaluation, although we do not have longitudinal data for
the younger individuals as they age, when such disorders
typically manifest.
To our knowledge, this study is the first to report the ages
ofhighest risk for comorbidpsychiatricdisorders aswell as the
relationship of demographic and clinical characteristics with
overall disorder burden in TS. For most disorders, the age of
greatest risk began before 5 years, with high risk for anxiety
and DBD continuing into adolescence and risk for depressive
disorders continuing into young adulthood. Previous re-
search has demonstrated that TS symptoms typically emerge
between the ages of 5 and 7 years13,40; ADHD generally ap-
pears 2 to 3 years earlier41 and OCD 5 to 6 years later.42 In this
study, DBD and ADHD began at or before age 5 years, prior to
tic onset. In contrast to the findings of population-based epi-
demiologic studies,43,44 OCD and anxiety disorders also be-
gan early in the patients in our study, typically within 1 year
of the onset of tics (withmany cases beginning earlier);mood
disorders had amore distributed age-at-onset pattern, begin-
ning as early as age 5 years andbecomingmore frequent at ap-
proximately 7 to 8 years. These results, in combination with
thehigh likelihoodofdevelopingamooddisorder, anxietydis-
order, or DBD, suggest that psychiatric assessments of TS-
affected children should begin early and continue through-
out adolescence and adulthood.
Our results also suggest that TS-affected children who
have concomitant OCD or a parent with ADHD should be care-
fully evaluated over time for the development of mood disor-
der, anxiety disorder, and DBD. In addition, adolescents, par-
ticularly those with OCD and/or ADHD, should be monitored
for the development of a substance use disorder. In a similar
manner, TS-affected children with ADHD should be evaluated
for other DBD and anxiety disorders. The association between
high tic severity and the number of non-ADHD/non-OCD
comorbidities is consistent with a previous study12 demon-
strating an association between tic severity and non-OCD
anxiety disorders.
Etiologic Relevance
The heritability estimates we observed confirm previous
research26,35 showing that TS, OCD, and ADHD are highly ge-
netically related. However, for what we believe to be the first
time, we also provide evidence of a strong genetic relation-
ship between these TS-related phenotypes and mood disor-
ders, anxiety disorders, and DBDs. Of particular interest, our
analyses suggest that the observed genetic correlations be-
tween TS and these disorders are better accounted for by an
underlying genetic relationshipwithADHDand, in the case of
mood disorders, by an underlying genetic relationship with
both ADHD and OCD. In non-TS samples, there is consider-
able evidence45 to support shared genetic variance between
ADHD and DBD and some data46 to support a shared genetic
diathesisunderlyingADHDandmajordepressivedisorder.Ge-
netic relationshipsbetweenOCDandmooddisordershavenot
previously been examined.Our findings are in linewith those
of a previous study that found no increased rates of ADHD47
or other non-OCD disorders, such as anxiety, affective, sub-
stanceabuse, andpsychoticdisorders,48 amongparentsofpro-
bandswith TS comparedwith controls, suggesting that these
disorders segregate independently fromTS.Our findings that
parental history of ADHD predicts psychiatric disorder bur-
den in TS-affected offspring, independent of parental history
Table 3. Bivariate Heritability of Comorbid DiagnosesWith TS/CMVTD, OCD, and ADHDa
Comorbid
Disorder
No Additional Diagnostic
Covariateb
Covariate
TSb OCD or ADHDb,c TS and OCD or ADHDb,c
RhoG
(SE)
P
Value
RhoE
(SE)
P
Value
RhoG
(SE)
P
Value
RhoE
(SE)
P
Value
RhoG
(SE)
P
Value
RhoE
(SE)
P
Value
RhoG
(SE)
P
Value
RhoE
(SE)
P
Value
ADHD
Mood 0.77
(0.14)
1.6
× 10−8
−0.32
(0.14)
2.6
× 10−2
0.74
(0.15)
3.9
× 10−7
0.31
(0.15)
.03 0.68
(0.18)
8.6
× 10−5
−0.29
(0.14)
.04 0.70
(0.18)
2.3
× 10−5
−0.36
(0.15)
.02
Anxiety 0.59
(0.12)
3.2
× 10−6
0.54
(0.13)
5.0
× 10−5
0.40
(0.15)
7.7
× 10−3
0.43
(0.14)
3.2
× 10−3
Disruptive
behavior
0.68
(0.15)
1.9
× 10−5
0.66
(0.16)
6.9
× 10−5
0.62
(0.17)
5.3
× 10−4
0.61
(0.17)
6.2
× 10−4
OCD
Mood 0.59
(0.13)
3.5
× 10−5
0.34
(0.11)
3.2
× 10−3
0.53
(0.15)
1.1
× 10−3
0.40
(0.11)
7.2
× 10−4
0.47
(0.17)
.01 0.43
(0.10)
1.3
× 10−4
0.41
(0.18)
.04 0.48
(0.11)
3.8
× 10−5
Anxiety 0.40
(0.12)
2.7
× 10−3
0.55
(0.11)
4.2
× 10−6
0.34
(0.13)
.02 0.55
(0.11)
1.2
× 10−5
0.60
(0.10)
2.4
× 10−7
0.62
(0.11)
3.6
× 10−7
Disruptive
behavior
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; CMVTD, chronic
motor and vocal tic disorder; OCD, obsessive-compulsive disorder; OR, odds
ratio; RhoE, environmental correlation; RhoG, genetic correlation; TS, Tourette
syndrome.
a RhoG and RhoE between TS/CMVTD and groups of comorbid disorders were
estimated; if RhoGwas significant, ADHD and OCDwere added separately as
covariates to assess the independent association between TS/CMVTD and the
given comorbid disorders. Subsequently, a series of bivariate analyses with
ADHD and OCDwas conducted for disorders with a significant RhoGwith TS
to determine the unique contributions of ADHD and OCD to the RhoG
between TS and each of these disorders (mood, anxiety, and disruptive
behavior disorders). Blank cells represent nonsignificant correlations (ie,
P > .05).
bAll analyses included sex, age, and sex by age as covariates.
c In bivariate analyses with ADHD, OCD (not ADHD) was included as a covariate;
conversely, in bivariate analyses with OCD, ADHD (not OCD) was included as a
covariate.
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of TS and OCD, provides additional support for the observed
genetic relationshipsbetweenpsychiatricdisordersandADHD.
Limitations
This study has several limitations. First, our data are cross-
sectional; thus, we could not assess causation (eg, whether
clinical characteristics predicted subsequent disorder onset).
Second, thepredominately clinic-based recruitmentmayhave
biased our sample to participants with more severe, comor-
bid, or familial TS, limiting generalizability. This concern is
somewhat mitigated by the presence of parents and siblings
with previously undiagnosed TS, who were typically less se-
verelyaffected.Third, althoughconsistentwithprevious stud-
ies, the total psychiatric burden identified in thepresent study
is likely anunderestimate given that somedisorderswere not
assessed (eg, pervasive developmental disorders) and not ev-
eryone had passed the age of risk for all disorders. Specifi-
cally, parents were not routinely assessed for certain child-
hood disorders (eg, elimination disorders) and children were
not assessed for schizophrenia, although they were evalu-
ated for psychosis. In addition, the lifetime rates of schizo-
phrenia, bipolar disorder, and substance use disorders could
be attenuated by an ascertainment bias (ie, the children and
adolescents in our sample may have developed these adult-
onset disorders later in life). Fourth, ADHD severity was not
uniformly assessed. Fifth, we did not have reliable data re-
garding the recruitmentmethods (ie, Tourette Syndrome As-
sociation vs specialty clinics), and the characteristics of par-
ticipants may vary by recruitment method. Sixth, pervasive
developmental disorders were not systematically assessed or
uniformly excluded; future studies should examine patterns
of comorbidity between TS and pervasive developmental
disorders.49 Finally, because theparent genetic study focused
onsiblingpairs andparent-child trios, theheritabilitiesmaybe
underestimates because the algorithm used by SOLAR is best
suited to analysis of multigenerational families.
Conclusions
This study provides important new data regarding the preva-
lence, predictors, and ages of the highest risk for psychiatric
illness among individuals affectedwithTS, aswell aswhatwe
believe to be the first formal evaluation of the etiologic rela-
tionships between disorders other than OCD and ADHD. The
key clinical findings, that mood disorders, anxiety disorders,
and DBDs are very common among TS-affected individuals,
tend to begin early in life, and are highly associated with co-
morbid OCD and ADHD, are of direct and immediate rel-
evance forpractitioners. Thegenetic analyses advanceourun-
derstandingof theetiologic relationshipsbetweenTSandother
psychiatricdisorders andprovidea framework for future stud-
ies aimed at better understanding these complex, interre-
lated syndromes.
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